Advertisement
Screener

Merck & Co., Inc. (MRK) Other Comprehensive Income (Loss), Net of Tax

2.2 / 5 stars · 50/112 Roast Me

Merck & Co., Inc. Other Comprehensive Income (Loss), Net of Tax

Merck & Co., Inc. (MRK) reported Other Comprehensive Income (Loss), Net of Tax of $118.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-07

  • Merck & Co., Inc. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was $118.00M.
  • Merck & Co., Inc. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was $227.00M.
  • Merck & Co., Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-12-31 was $915.00M, a 114.79% increase year-over-year.
  • Merck & Co., Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $219.00M.
  • Merck & Co., Inc. other comprehensive income (loss), net of tax for fiscal 2025 was $658.00M, a 204.63% increase from fiscal 2024.
  • Merck & Co., Inc. other comprehensive income (loss), net of tax for fiscal 2024 was $216.00M.
  • Merck & Co., Inc. other comprehensive income (loss), net of tax for fiscal 2023 was -$393.00M.
  • Merck & Co., Inc. other comprehensive income (loss), net of tax for fiscal 2022 was -$339.00M, a 119.31% decline from fiscal 2021.
Period endOther Comprehensive Income (Loss), Net of Tax 3 monthOther Comprehensive Income (Loss), Net of Tax 6 monthOther Comprehensive Income (Loss), Net of Tax 9 monthOther Comprehensive Income (Loss), Net of Tax 12 month
2026-06-30$118.00M
10-Q · filed 2026-08-07
$345.00M
10-Q · filed 2026-08-07
$1.26B
derived: sum of 3 quarters · filed 2026-08-07
$1.48B
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31$227.00M
10-Q · filed 2026-05-04
$1.14B
derived: sum of 2 quarters · filed 2026-05-04
$1.36B
derived: sum of 3 quarters · filed 2026-05-04
$905.00M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31$915.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$1.13B
derived: sum of 2 quarters · filed 2026-02-24
$678.00M
derived: sum of 3 quarters · filed 2026-08-07
$658.00M
10-K · filed 2026-02-24
2025-09-30$219.00M
10-Q · filed 2025-11-05
-$237.00M
derived: sum of 2 quarters · filed 2026-08-07
-$257.00M
10-Q · filed 2025-11-05
$169.00M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30-$456.00M
10-Q · filed 2026-08-07
-$476.00M
10-Q · filed 2026-08-07
-$50.00M
derived: sum of 3 quarters · filed 2026-08-07
-$60.00M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31-$20.00M
10-Q · filed 2026-05-04
$406.00M
derived: sum of 2 quarters · filed 2026-05-04
$396.00M
derived: sum of 3 quarters · filed 2026-05-04
$309.00M
derived: sum of 4 quarters · filed 2026-05-04
2024-12-31$426.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$416.00M
derived: sum of 2 quarters · filed 2026-02-24
$329.00M
derived: sum of 3 quarters · filed 2026-02-24
$216.00M
10-K · filed 2026-02-24
2024-09-30-$10.00M
10-Q · filed 2025-11-05
-$97.00M
derived: sum of 2 quarters · filed 2025-11-05
-$210.00M
10-Q · filed 2025-11-05
-$455.00M
derived: sum of 4 quarters · filed 2026-02-24
2024-06-30-$87.00M
10-Q · filed 2025-08-05
-$200.00M
10-Q · filed 2025-08-05
-$445.00M
derived: sum of 3 quarters · filed 2026-02-24
-$461.00M
derived: sum of 4 quarters · filed 2026-02-24
2024-03-31-$113.00M
10-Q · filed 2025-05-02
-$358.00M
derived: sum of 2 quarters · filed 2026-02-24
-$374.00M
derived: sum of 3 quarters · filed 2026-02-24
-$391.00M
derived: sum of 4 quarters · filed 2026-02-24
2023-12-31-$245.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$261.00M
derived: sum of 2 quarters · filed 2026-02-24
-$278.00M
derived: sum of 3 quarters · filed 2026-02-24
-$393.00M
10-K · filed 2026-02-24
2023-09-30-$16.00M
10-Q · filed 2024-11-06
-$33.00M
derived: sum of 2 quarters · filed 2024-11-06
-$148.00M
10-Q · filed 2024-11-06
-$173.00M
derived: sum of 4 quarters · filed 2025-02-25
2023-06-30-$17.00M
10-Q · filed 2024-08-05
-$132.00M
10-Q · filed 2024-08-05
-$157.00M
derived: sum of 3 quarters · filed 2025-02-25
-$573.00M
derived: sum of 4 quarters · filed 2025-02-25
2023-03-31-$115.00M
10-Q · filed 2024-05-03
-$140.00M
derived: sum of 2 quarters · filed 2025-02-25
-$556.00M
derived: sum of 3 quarters · filed 2025-02-25
-$514.00M
derived: sum of 4 quarters · filed 2025-02-25
2022-12-31-$25.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
-$441.00M
derived: sum of 2 quarters · filed 2025-02-25
-$399.00M
derived: sum of 3 quarters · filed 2025-02-25
-$339.00M
10-K · filed 2025-02-25
2022-09-30-$416.00M
10-Q · filed 2023-11-03
-$374.00M
derived: sum of 2 quarters · filed 2023-11-03
-$314.00M
10-Q · filed 2023-11-03
-$153.00M
derived: sum of 4 quarters · filed 2024-02-26
2022-06-30$42.00M
10-Q · filed 2023-08-07
$102.00M
10-Q · filed 2023-08-07
$263.00M
derived: sum of 3 quarters · filed 2024-02-26
$301.00M
derived: sum of 4 quarters · filed 2024-02-26
2022-03-31$60.00M
10-Q · filed 2023-05-05
$221.00M
derived: sum of 2 quarters · filed 2024-02-26
$259.00M
derived: sum of 3 quarters · filed 2024-02-26
$1.80B
derived: sum of 4 quarters · filed 2024-02-26
2021-12-31$161.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26
$199.00M
derived: sum of 2 quarters · filed 2024-02-26
$1.74B
derived: sum of 3 quarters · filed 2024-02-26
$1.76B
10-K · filed 2024-02-26
2021-09-30$38.00M
10-Q · filed 2022-11-03
$1.58B
derived: sum of 2 quarters · filed 2022-11-03
$1.59B
10-Q · filed 2022-11-03
$1.34B
derived: sum of 4 quarters · filed 2023-02-24
2021-06-30$1.54B
10-Q · filed 2022-08-05
$1.56B
10-Q · filed 2022-08-05
$1.31B
derived: sum of 3 quarters · filed 2023-02-24
$1.32B
derived: sum of 4 quarters · filed 2023-02-24
2021-03-31$12.00M
10-Q · filed 2022-05-05
-$239.00M
derived: sum of 2 quarters · filed 2023-02-24
-$229.00M
derived: sum of 3 quarters · filed 2023-02-24
-$231.00M
derived: sum of 4 quarters · filed 2023-02-24
2020-12-31-$251.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24
-$241.00M
derived: sum of 2 quarters · filed 2023-02-24
-$243.00M
derived: sum of 3 quarters · filed 2023-02-24
-$441.00M
10-K · filed 2023-02-24
2020-09-30$10.00M
10-Q · filed 2021-11-05
$8.00M
derived: sum of 2 quarters · filed 2021-11-05
-$190.00M
10-Q · filed 2021-11-05
-$993.00M
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30-$2.00M
10-Q · filed 2021-08-09
-$200.00M
10-Q · filed 2021-08-09
-$1.00B
derived: sum of 3 quarters · filed 2022-02-25
-$1.03B
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31-$198.00M
10-Q · filed 2021-05-05
-$1.00B
derived: sum of 2 quarters · filed 2022-02-25
-$1.03B
derived: sum of 3 quarters · filed 2022-02-25
-$1.04B
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31-$803.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
-$831.00M
derived: sum of 2 quarters · filed 2022-02-25
-$847.00M
derived: sum of 3 quarters · filed 2022-02-25
-$648.00M
10-K · filed 2022-02-25
2019-09-30-$28.00M
10-Q · filed 2020-11-05
-$44.00M
derived: sum of 2 quarters · filed 2020-11-05
$155.00M
10-Q · filed 2020-11-05
-$239.00M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30-$16.00M
10-Q · filed 2020-08-05
$183.00M
10-Q · filed 2020-08-05
-$211.00M
derived: sum of 3 quarters · filed 2021-02-25
-$240.00M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$199.00M
10-Q · filed 2020-05-06
-$195.00M
derived: sum of 2 quarters · filed 2021-02-25
-$224.00M
derived: sum of 3 quarters · filed 2021-02-25
-$286.00M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31-$394.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
-$423.00M
derived: sum of 2 quarters · filed 2021-02-25
-$485.00M
derived: sum of 3 quarters · filed 2021-02-25
-$361.00M
10-K · filed 2021-02-25
2018-09-30-$29.00M
10-Q · filed 2019-11-05
-$91.00M
derived: sum of 2 quarters · filed 2019-11-05
$33.00M
10-Q · filed 2019-11-05
$68.00M
derived: sum of 4 quarters · filed 2020-02-26
2018-06-30-$62.00M
10-Q · filed 2019-08-06
$62.00M
10-Q · filed 2019-08-06
$97.00M
derived: sum of 3 quarters · filed 2020-02-26
$246.00M
derived: sum of 4 quarters · filed 2020-02-26
2018-03-31$124.00M
10-Q · filed 2019-05-08
$159.00M
derived: sum of 2 quarters · filed 2020-02-26
$308.00M
derived: sum of 3 quarters · filed 2020-02-26
$294.00M
derived: sum of 4 quarters · filed 2020-02-26
2017-12-31$35.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
$184.00M
derived: sum of 2 quarters · filed 2020-02-26
$170.00M
derived: sum of 3 quarters · filed 2020-02-26
$316.00M
10-K · filed 2020-02-26
2017-09-30$149.00M
10-Q · filed 2018-11-06
$135.00M
derived: sum of 2 quarters · filed 2018-11-06
$281.00M
10-Q · filed 2018-11-06
-$693.00M
derived: sum of 4 quarters · filed 2019-02-27
2017-06-30-$14.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
$132.00M
10-Q · filed 2018-08-07
-$842.00M
derived: sum of 3 quarters · filed 2019-02-27
-$1.01B
derived: sum of 4 quarters · filed 2019-02-27
2017-03-31$146.00M
10-Q · filed 2018-05-08
-$828.00M
derived: sum of 2 quarters · filed 2019-02-27
-$994.00M
derived: sum of 3 quarters · filed 2019-02-27
-$886.00M
derived: sum of 4 quarters · filed 2019-02-27
2016-12-31-$974.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27
-$1.14B
derived: sum of 2 quarters · filed 2019-02-27
-$1.03B
derived: sum of 3 quarters · filed 2019-02-27
-$1.08B
10-K · filed 2019-02-27
2016-09-30-$166.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
-$58.00M
derived: sum of 2 quarters · filed 2017-11-07
-$104.00M
10-Q · filed 2017-11-07
$321.00M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30$108.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
$62.00M
10-Q · filed 2017-08-08
$487.00M
derived: sum of 3 quarters · filed 2018-02-27
$246.00M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31-$46.00M
10-Q · filed 2017-05-09
$379.00M
derived: sum of 2 quarters · filed 2018-02-27
$138.00M
derived: sum of 3 quarters · filed 2018-02-27
-$27.00M
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31$425.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
$184.00M
derived: sum of 2 quarters · filed 2018-02-27
$19.00M
derived: sum of 3 quarters · filed 2018-02-27
$175.00M
10-K · filed 2018-02-27
2015-09-30-$241.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07
-$406.00M
derived: sum of 2 quarters · filed 2016-11-07
-$250.00M
10-Q · filed 2016-11-07
-$1.57B
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30-$165.00M
10-Q · filed 2015-08-06
-$9.00M
10-Q · filed 2016-08-08
-$1.33B
derived: sum of 3 quarters · filed 2017-02-28
-$1.89B
derived: sum of 4 quarters · filed 2017-02-28
2015-03-31$156.00M
10-Q · filed 2016-05-09
-$1.17B
derived: sum of 2 quarters · filed 2017-02-28
-$1.72B
derived: sum of 3 quarters · filed 2017-02-28
-$1.99B
derived: sum of 4 quarters · filed 2017-02-28
2014-12-31-$1.32B
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
-$1.88B
derived: sum of 2 quarters · filed 2017-02-28
-$2.14B
derived: sum of 3 quarters · filed 2017-02-28
-$2.13B
10-K · filed 2017-02-28
2014-09-30-$554.00M
10-Q · filed 2014-11-10
-$819.00M
derived: sum of 2 quarters · filed 2015-08-06
-$801.00M
10-Q · filed 2015-11-05
$1.70B
derived: sum of 4 quarters · filed 2016-02-26
2014-06-30-$265.00M
10-Q · filed 2015-08-06
-$247.00M
10-Q · filed 2015-08-06
$2.25B
derived: sum of 3 quarters · filed 2016-02-26
$2.32B
derived: sum of 4 quarters · filed 2016-02-26
2014-03-31$18.00M
10-Q · filed 2015-05-07
$2.52B
derived: sum of 2 quarters · filed 2016-02-26
$2.58B
derived: sum of 3 quarters · filed 2016-02-26
$2.45B
derived: sum of 4 quarters · filed 2016-02-26
2013-12-31$2.50B
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26
$2.56B
derived: sum of 2 quarters · filed 2016-02-26
$2.43B
derived: sum of 3 quarters · filed 2016-02-26
$2.48B
10-K · filed 2016-02-26
2013-09-30$62.00M
10-Q · filed 2014-11-10
-$69.00M
derived: sum of 2 quarters · filed 2014-11-10
-$16.00M
10-Q · filed 2014-11-10
-$1.66B
derived: sum of 4 quarters · filed 2015-02-27
2013-06-30-$131.00M
10-Q · filed 2014-08-07
-$78.00M
10-Q · filed 2014-08-07
-$1.72B
derived: sum of 3 quarters · filed 2015-02-27
-$1.63B
derived: sum of 4 quarters · filed 2015-02-27
2013-03-31$53.00M
10-Q · filed 2014-05-08
-$1.59B
derived: sum of 2 quarters · filed 2015-02-27
-$1.50B
derived: sum of 3 quarters · filed 2015-02-27
-$1.41B
derived: sum of 4 quarters · filed 2015-02-27
2012-12-31-$1.64B
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
-$1.56B
derived: sum of 2 quarters · filed 2015-02-27
-$1.47B
derived: sum of 3 quarters · filed 2015-02-27
-$1.55B
10-K · filed 2015-02-27
2012-09-30$86.00M
10-Q · filed 2013-11-07
$177.00M
derived: sum of 2 quarters · filed 2013-11-07
$92.00M
10-Q · filed 2013-11-07
-$327.00M
derived: sum of 4 quarters · filed 2014-02-27
2012-06-30$91.00M
10-Q · filed 2013-08-07
$6.00M
10-Q · filed 2013-08-07
-$413.00M
derived: sum of 3 quarters · filed 2014-02-27
-$350.00M
derived: sum of 4 quarters · filed 2014-02-27
2012-03-31-$85.00M
10-Q · filed 2013-05-09
-$504.00M
derived: sum of 2 quarters · filed 2014-02-27
-$441.00M
derived: sum of 3 quarters · filed 2014-02-27
-$47.00M
derived: sum of 4 quarters · filed 2014-02-27
2011-12-31-$419.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27
-$356.00M
derived: sum of 2 quarters · filed 2014-02-27
$38.00M
derived: sum of 3 quarters · filed 2014-02-27
$84.00M
10-K · filed 2014-02-27
2011-09-30$63.00M
10-Q · filed 2012-11-09
$457.00M
derived: sum of 2 quarters · filed 2012-11-09
$503.00M
10-Q · filed 2012-11-09
2011-06-30$394.00M
10-Q · filed 2012-08-07
$440.00M
10-Q · filed 2012-08-07
2010-12-31-$449.00M
10-K · filed 2013-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
AbbVie Inc. (ABBV)United States$468.180B70.37
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
JOHNSON & JOHNSON (JNJ)United States$652.528B29.10
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60